Omidenepag Isopropyl Patent Expiration
Omidenepag Isopropyl is Used for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It was first introduced by Ocuvex Therapeutics Inc
Omidenepag Isopropyl Patents
Given below is the list of patents protecting Omidenepag Isopropyl, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Omlonti | US11666563 | Pharmaceutical preparation containing pyridyl aminoacetic acid compound | Jul 16, 2039 | Ocuvex Therap |
| Omlonti | US10774072 | Crystal of N-substituted sulfonamide compound | Jun 10, 2035 | Ocuvex Therap |
| Omlonti | US10179127 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Jan 08, 2035 | Ocuvex Therap |
| Omlonti | US10702511 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Jan 08, 2035 | Ocuvex Therap |
| Omlonti | US10765750 | Pharmaceutical composition containing pyridylaminoacetic acid compound | Jan 08, 2035 | Ocuvex Therap |
| Omlonti | US11197849 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Jan 08, 2035 | Ocuvex Therap |
| Omlonti | US11793798 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Jan 08, 2035 | Ocuvex Therap |
| Omlonti | US9415038 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Jan 08, 2035 | Ocuvex Therap |
| Omlonti | USRE48183 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Jan 08, 2035 | Ocuvex Therap |
| Omlonti | US8648097 | Pyridylaminoacetic acid compound | Oct 13, 2029 | Ocuvex Therap |
| Omlonti | US8685986 | Medical composition for treatment or prophylaxis of glaucoma | Oct 13, 2029 | Ocuvex Therap |
Omidenepag Isopropyl's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List